Siege Pharmaceuticals
Siege Pharmaceuticals focuses on developing innovative cancer drugs that target and starve cancer cells using a naturally-occurring molecule.
Company Overview
Siege Pharmaceuticals is focused on developing innovative cancer treatments. The company is dedicated to creating drugs that leverage naturally-occurring molecules. These molecules specifically target and starve cancer cells, aiming to improve the effectiveness of cancer therapies.
Research and Development
Siege Pharmaceuticals conducts extensive research and development in the field of oncology. The company explores the use of naturally-occurring molecules as a basis for new drugs designed to combat cancer. These molecules work by starving cancer cells, aiming to reduce their ability to grow and spread.
Drug Development
At the core of Siege Pharmaceuticals' efforts is the development of new cancer drugs. These drugs are formulated using naturally-occurring molecules that have been identified for their ability to starve cancer cells. The goal is to create treatments that are more efficient and targeted, potentially offering new hope for patients.
Cancer Therapy Innovation
Siege Pharmaceuticals is at the forefront of innovation in cancer therapy. By focusing on naturally-occurring molecules that starve cancer cells, the company seeks to introduce a novel approach to cancer treatment. This method aims to disrupt the growth and survival of cancer cells, providing an alternative to traditional therapies.